Pediatrix Medical Group Inc is a leading healthcare provider specializing in delivering pediatric healthcare services, with a primary focus on neonatal, maternal-fetal, and pediatric behavioral health care
The company operates through a network of highly skilled physicians and healthcare professionals, offering a range of services that include critical care for newborns, outpatient clinics, and specialty care initiatives aimed at improving health outcomes for children and their families. By integrating clinical excellence with compassionate care, Pediatrix aims to meet the unique needs of pediatric patients while also supporting their families throughout the healthcare process.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Pediatric healthcare provider Pediatrix Medical Group (NYSEMD) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 1.2% year on year to $502.4 million. Its non-GAAP profit of $0.51 per share was 39.9% above analysts’ consensus estimates.
Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company projects 2025 adjusted EBITDA of $215 million–$235 million.
